Cargando…
Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot
Autores principales: | Varikasuvu, Seshadri Reddy, Dutt, Naveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251352/ https://www.ncbi.nlm.nih.gov/pubmed/32473231 http://dx.doi.org/10.1016/j.jinf.2020.05.038 |
Ejemplares similares
-
Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19
por: Varikasuvu, Seshadri Reddy, et al.
Publicado: (2020) -
Diabetes and COVID-19: A pooled analysis related to disease severity and mortality
por: Varikasuvu, Seshadri Reddy, et al.
Publicado: (2021) -
D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies
por: Varikasuvu, Seshadri Reddy, et al.
Publicado: (2021) -
Atherosclerostic cardiovascular disease risk score: Are Indians underestimating the risk of cardiovascular disease?
por: Kumar, Ashish, et al.
Publicado: (2019) -
Rheumatoid arthritis associated interstitial lung disease: 1 year is too much to exclude methotrexate-induced pulmonary involvement
por: Kuwal, Ashok, et al.
Publicado: (2016)